October 18, 2022
November 01, 2022
November 06, 2022
November 01, 2022
Read MoreOctober 18, 2022
Read MoreOctober 27, 2022
Read MoreJune 28, 2023
The global brain implants market surpassed USD 5.85 billion in 2022 and is projected to hit around USD 14.24 billion by 2032, growing at a CAGR of 9.3% from 2023 to 2032, as a result of the increasing adoption of advanced technology and rising preval...
June 27, 2023
The global lung disease therapeutics market size reached USD 81.2 billion in 2022 and is anticipated to hit around USD 146.1 billion by 2032, expanding at a CAGR of 6.1% from 2023 to 2032, as a result of rising advancement in targeted and personalize...
June 14, 2023
The global non-oncology precision medicine market size reached USD 70.16 billion in 2022 and is estimated to surpass around USD 163.5 billion by 2032, expanding at a CAGR of 8.7% from 2023 to 2032, as a result of rising clinical trials and the increa...
June 13, 2023
The non-invasive blood glucose monitoring system market is estimated to grow from USD 21.76 million in 2022 at 25.0% CAGR (2023-2032) to reach an estimated USD 202.73 million by 2032, as a result of rising diabetes prevalence and repeated diabetic co...
June 12, 2023
The global animal vaccine market is estimated to grow from USD 14.27 billion in 2022 at 10% CAGR (2023-2032) to reach an estimated USD 36.91 billion by 2032, as a result of a rising focus on food safety and security. An estimated 75% of newly emer...
June 06, 2023
The global diabetes drugs market is estimated to grow from USD 61.87 billion in 2022 at 6.7% CAGR (2023-2032) to reach an estimated USD 118 billion by 2032, as a result of the rising prevalence of diabetes, and rising patient support. More ...
June 05, 2023
The global precision oncology market is estimated to grow from USD 100.06 billion in 2022 at 9.9% CAGR (2023-2032) to reach an estimated USD 258.35 billion by 2032, as a result of rising cancer prevalence and the increasing demand for personalized me...
June 02, 2023
The global generic drugs market size is estimated to grow from USD 439.37 billion in 2022 at 5.3% CAGR (2023-2032) to reach an estimated USD 738.53 billion by 2032, as a result of rising generic drug approvals and increased overall funding in the gen...
May 09, 2023
The global biosimilar market size is estimated to grow from USD 25,125.36 million in 2022 at 17.6% CAGR (2023-2032) to reach an estimated USD 1,26,019.67 million by 2032, as a result of the rising prevalence of cancer, and cost effectivity of b...
March 20, 2023
The global antibodies drug market size reached USD 200.18 billion in 2022 and is expected to exceed USD 605.8 billion by 2032, expanding at a CAGR of 10.8% between 2023 and 2032. The increase in the production of monoclonal antibodies is leading to h...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com